Equibles does not estimate personal net worth.
Get an email with a short summary when BeOne Medicines Ltd. publishes a filing, an earnings call transcript or a press release.
Get ONC alertsMark Lanasa has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for BeOne Medicines Ltd. on August 5, 2026. BeOne Medicines Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BeOne Medicines Ltd. includes Mr. John V. Oyler (CEO and Board Member), John V. Oyler (Chairman), Mr. Aaron Rosenberg (CFO) and 7 others.
“We're very excited about our PRMT-5 program and look forward to the initial disclosure that's upcoming at ESMO.”
“So, yes, we have brought a lot of molecules into the clinic, and it is our aspiration to bring additional internally discovered as well as some partnered molecules into the clinic.”
“So we're really pleased with the progress that's been made with our B7H4 targeting ADC. This has progressed swiftly through Phase I dose escalation, and as you heard from Lai, we are planning to disclose efficacy and safety data for the dose escalation in the first half of the year at a major medical congress.”
Source not stated
Biotechnology · Healthcare
